Kindred Healthcare Inc: (NYSE: KND)

$12.19

0.03 (0.25%)

Volume 8,525

May 20 09:40 AM ET

Zacks Rank: 2-Buy

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		12.02 - 12.19
	
		52wk Low - High
		7.75 - 12.76
	
		Previous Close
		12.16
	
		Avg. Volume
		314,106
	
		Industry
		MED-NURSING HMS
	
		Market Cap
		647.84 M
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		1.59
	
		PE (Forward)
		10.28
	
		Current Year Est.
		1.18
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		2
Buy

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		231 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/8/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            10.28
                        
                            PEG Ratio
                            1.03
                        
                            Current Year Est.
                            1.18
                        
                            Current Quarter Estimate
                            0.34
                        
                            Most Accurate Estimate
                            0.34
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-08-2013
                        
                            EPS Last Year
                            1.57
                        
                            Expected Earnings Growth
                            10.00%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business.   
Full KND Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
KND Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.34	0.14	1.18	1.30
Number of Estimates	3	3	4	4
Low Estimate	0.29	0.10	1.07	1.20
High Estimate	0.43	0.17	1.27	NA
Year Ago EPS	0.41	0.21	1.52	1.18
EPS Growth	-17.89%	-33.33%	-22.20%	9.73%

More KND Estimates

Average Earnings Estimates for KND

EPS Growth for KND

Industry Analysis

Name	Symbol	Previous Close
KINDRED HLTHCR	KND	12.16
BROOKDALE SENR	BKD	29.97
CAPITAL SR LIVG	CSU	26.49
CONCORD MED-ADR	CCM	4.12
DIVERSICARE HLT	DVCR	4.71
EMERITUS CORP	ESC	25.99
TEAM HEALTH HLD	TMH	39.72
ENSIGN GROUP	ENSG	36.69
FIVE STAR QLTY	FVE	4.90
SKILLED HLTHCR	SKH	6.80

Sector:Medical>> Industry:MED-NURSING HMS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Bearish MACD for Kindred Healthcare, Inc.

Apr 25, 2013

Ventas Signs New Lease Agreement

May 25, 2012

Report for KND

May 08, 2013

More KND Zacks Commentary

Financials

EPS TTM	1.57
Sales	6,181
Net Income	-56
Price/Earnings	7.75
Price/Book	0.50
Price/Cash Flow	2.16
Price/Sales	0.11

More KND Financials

News

This Therapy Clinic Operator is a Long Term Buy - TheMotleyFool

May 10, 2013

Kindred Healthcare Announces Additional Integrated Care Market Development Plans and Home Health Acquisitions - Benzinga

Apr 29, 2013

Top 4 Small-Cap Stocks In The Long-Term Care Facilities Industry With The Lowest PEG Ratio - Benzinga

Mar 22, 2013

Kindred Healthcare, Inc. (KND) Executive VP and CFO Richard A Lechleiter sells 15,000 Shares - GuruFocus

Mar 11, 2013

Earnings Scheduled For February 25, 2013 - Benzinga

Feb 25, 2013

US Stock Futures Up Ahead Of Lowe`s Earnings - Benzinga

Feb 25, 2013

Coming Soon: Kindred Healthcare Earnings - TheMotleyFool

Feb 4, 2013

Kindred Healthcare, Inc. (KND) Executive VP and CFO Richard A Lechleiter sells 10,000 Shares - GuruFocus

Nov 7, 2012

See All News Stories on KND

Broker Recommendations

Current ABR	2.83
ABR (Last Week)	2.83
# of recs in ABR	6
Average Target Price	11.83
Industry Rank by ABR	231 out of 265
Rank in Industry	1 out of 11

More KND Broker Recommendations

Username: Password:

Remember me [?]

Forgot Password

New Member

Kindred Healthcare Inc: (NYSE: KND)

$12.19

0.03 (0.25%)

Volume 8,525

May 20 09:40 AM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description